SAHPRA and the SAPC Crack Down on Unlawful Manufacturing of Unregistered GLP-1 Medicines
Pretoria, 23 May 2026 – The South African Health Products Regulatory Authority (SAHPRA), in collabor...
23 May, 26
Pretoria, 23 May 2026 – The South African Health Products Regulatory Authority (SAHPRA), in collabor...
23 May, 26Pretoria, 24 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) today brie...
24 March, 26Pretoria, 20 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) will brief...
20 March, 26The South African Health Products Regulatory Authority (SAHPRA) recently hosted a two-day workshop i...
04 March, 26The South African Health Products Regulatory Authority (SAHPRA) would like to inform healthcare prof...
06 June, 25There have been several cases around the world in which Tranexamic acid has been administered intrat...
21 December, 23The South African Health Products Regulatory Authority (SAHPRA) would like to inform you of a signal...
19 October, 21In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Product...
10 November, 20Bayer has detected a risk for the formation of nitrosamine (N-Nitroso-Meglumine) in Gastrografin/Urografin.
Bayer has detected a risk for the formation of nitrosamine (N-Nitroso-Meglumine) in Gastrografin/Urografin.
This recall is initiated due to an out-of-specification result in the Aerodynamic Assessment of Fine Particles test [by Andersen Cascade Impactor test (APSD)] for Fluticasone Propionate during stability testing.